UAE Healthcare Sector Outlook 2022

 Table of Contents
1. Analyst View
2. Research Methodology
3. UAE Healthcare Market Overview
4. Market Attractions
     4.1 Favorable Demographics
     4.2 Epidemiological Backdrop
            4.2.1 Diabetes
            4.2.2 Hypertension and Obesity
            4.2.3 Cancer
5. Emerging Market Trends
     5.1 Rising Medical Tourism Driving Healthcare Industry
     5.2 Mandatory Health Insurance Accelerating the Industry
     5.3 Government Initiatives Forming Comprehensive Healthcare System
     5.4 Mergers and Acquisition Driving Healthcare Industry
6. Hospital Services Market
     6.1 Hospital and Bed Capacity
            6.1.1 MOH Hospitals
            6.1.2 Other Government Sector Hospitals
            6.1.3 Private Sector Hospitals
     6.2 Hospital Bed Demand Projection till 2022
7. Healthcare Services in Emirates
     7.1 Dubai
            7.1.1 Overview
            7.1.2 Healthcare Infrastructure
            7.1.3 Healthcare Professionals
            7.1.4 Future Outlook
     7.2 Abu Dhabi
            7.2.1 Overview
            7.2.2 Healthcare Infrastructure
            7.2.3 Healthcare Professionals
            7.2.4 Future Outlook
     7.3 Sharjah
            7.3.1 Overview
            7.3.2 Healthcare Infrastructure
            7.3.3 Healthcare Professionals
            7.3.4 Future Outlook
     7.4 Other Emirates
            7.4.1 Ajman
            7.4.2 Ras Al Khaimah (R.A.K)
            7.4.3 Fujairah
            7.4.4 Umm al-Quwain (U.A.Q)
8. Medical Devices Market Outlook 2022
     8.1 Market Overview
     8.2 Market Segmentation
     8.3 Imports and Domestic Production
     8.4 Regulatory Environment
9. Pharmaceutical Market Outlook 2022
     9.1 Market Overview
     9.2 Prescription and OTC Drugs
     9.3 Generic and Patented Drugs
     9.4 Imported and Domestically Manufactured Drugs
     9.5 Regulatory Environment
10. Government Initiatives
       10.1 Health Programs
       10.2 Focus on Training and Development of Healthcare Professionals
       10.3 Investment in Healthcare Infrastructure
       10.4 Regulatory Reforms
11. Competitive Landscape
       11.1 Hospital Services Industry
                11.1.1 NMC Healthcare LLC
                11.1.2 American Hospital
                11.1.3 GMC Clinincs
                11.1.4 Al Zahra Private Hospital
       11.2 Pharmaceutical Industry
                11.2.1 Julphar
                11.2.2 Neopharma
                11.2.3 Medpharma
                11.2.4 Globalpharma Co. LLC

List of Tables:

Table 4-1: Demographic Characteristics (2014 & 2020)
Table 6-1: Number of MOH Hospitals by Emirate (2012)
Table 6-2: Number of MOH Hospitals by Specialty (2012)
Table 6-3: Number of MOH Hospital Beds by District (2012)
Table 6-4: Number of MOH Hospital Beds by Specialty (2012)
Table 6-5: MOH Hospital Services to Inpatients by Specialty (2012)
Table 6-6: MOH Hospital Services to Outpatients by Specialty (2012)
Table 6-7: Other Government Sector Hospitals by District (2012)
Table 6-8: Number of Other Government Sector Hospital Beds (2012)
Table 6-9: Private Sector Hospitals by Emirate (2012)
Table 6-10: Number of Private Sector Hospital Beds by Emirate (2012)
Table 6-11: Private Sector Hospital Services to Patients (2012)
Table 7-1: Dubai - MOH Healthcare Infrastructure (2012)
Table 7-2: Dubai - Healthcare Professionals (2013)
Table 7-3: Abu Dhabi - Healthcare Infrastructure (2014)
Table 7-4: Abu Dhabi - Healthcare Professionals (2013)
Table 7-5: Sharjah - MOH Healthcare Infrastructure (2011)
Table 7-6: Sharjah - Healthcare Professionals (2013)
Table 7-7: Ajman - MOH Healthcare Infrastructure (2011)
Table 7-8: Ajman - Healthcare Professionals (2013)
Table 7-9: R.A.K - MOH Healthcare Infrastructure (2011)
Table 7-10: R.A.K - Healthcare Professionals (2013)
Table 7-11: Fujairah - MOH Healthcare Infrastructure (2011)
Table 7-12: Fujairah - Healthcare Professionals (2013)
Table 7-13: U.A.Q - MOH Healthcare Infrastructure (2011)
Table 7-14: U.A.Q - Healthcare Professionals (2013)
Table 9-1: Local Pahrmaceutical Industries, 2015
Table 9-2: Prescription of Drugs by Preferences
Table 10-1: Healthcare Regulatory Authorities
Table 11-1 : NMC Healthcare LLC - Financial Overview (Million US$)
Table 11-2: Julphar Pharmaceuticals - Production Capacity
Table 11-3: Julphur - Financial Overview (Billion US$)
Table 11-4: Neopharma - Production Capacity, (Million)
Table 11-5: Medpharma - Production Capacity
Table 11-6: Globalpharma - Production Facilities 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy